Prothrombin G20210a Mutation
Mostrando 1-7 de 7 artigos, teses e dissertações.
-
1. Trombofilias maternas hereditárias com e sem tromboembolismo venoso: resultados maternos e neonatais / Maternal inherited thrombophilias with or without venous thromboembolism: maternal and neonatal outcomes
The aim of this study was to evaluate differences in maternal and neonatal outcomes in pregnancies complicated by inherited thrombophilias between patients with and without venous thromboembolism. Despite increasing evidence in the literature indicating an association between inherited thrombophilias and adverse obstetric outcomes, doubts remain whether thro
Publicado em: 2010
-
2. Estudo de biomarcadores de trombose do acesso vascular em pacientes sob hemodiálise
Hemodialysis is a kind of blood filtration in which accumulated toxins and water are removed from the body. This treatment is indicated for patients in the end stage renal disease. Vascular access complications constitute about 20-25% of all hospitalizations in dialysed patients. The occurrence of thrombosis in the vascular access is a serious problem that m
Publicado em: 2009
-
3. InfluÃncia do fator V de Leiden e da mutaÃÃo g20210a no gene da protrombina no desenvolvimento de eventos trombÃticos no MunicÃpio de Fortaleza / Influence of factor v leiden and prothrombin g20210a mutation gene in the development of thrombosis at Fortaleza city
RESUMO As doenÃas trombÃticas constituem um sÃrio problema de saÃde pÃblica. Diversas desordens hereditÃrias e ambientais, que afetam o sistema fisiolÃgico anticoagulante, estÃo atualmente estabelecidas como fatores de risco para a ocorrÃncia do evento trombÃtico. Dentre os fatores hereditÃrios, as mutaÃÃes G1691A do gene do fator V e G20210A do
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 05/09/2008
-
4. Trombose da veia porta em crianças e adolescentes : deficiência das proteínas C, S e Antitrombina e pesquisa das mutações fator V Leiden, G20210A da Protrombina e C677T da Metileno-tetraidrofolato redutase
Objetivo: A trombose da veia porta é uma causa importante de hiper-tensão porta em crianças e adolescentes, porém, em uma proporção importante dos casos, não apresenta fator etiológico definido. O objetivo desse estudo é determinar a freqüência de deficiência das proteínas inibidoras da coagulação – proteínas C, S e antitrombina − e das m
Publicado em: 2007
-
5. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease
Sickle cell disease (SCD) is one of the most common inherited diseases in the world and the patients present notorious clinical heterogeneity. It is known that patients with SCD present activation of the blood coagulation and fibrinolytic systems, especially during vaso-occlusive crises, but also during the steady state of the disease. We determined if the p
Brazilian Journal of Medical and Biological Research. Publicado em: 09/08/2006
-
6. Defeito bioquÃmico em fator V, fator V de Leiden, em paciente jovem com trombose venosa profunda: estudo de caso
Inherited disturbances of the coagulation and fibrinolysis have been associated with thrombophilia. Trauma can be a precipitant of the deep vein thrombosis (DVT) in Factor V Leiden (FVL) carriers, the most common polymorphism cause of hereditary thrombophilia. The objective of this study was to analyze the case of a 15 years old boy, his parents and a contro
Publicado em: 2001
-
7. Genetic Polymorphisms in Venous Thrombosis and Pulmonary Embolism After Total Hip Arthroplasty: A Pilot Study
Deep venous thrombosis (DVT) after major orthopaedic surgery is a substantial concern. We asked whether the single or combined presence of thrombophilic genetic polymorphisms might further increase the already high risk for venous thrombosis and pulmonary embolism (PE) after THA. We therefore compared the prevalence of factor V Leiden, prothrombin G20210A, m
Springer-Verlag.